Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 44%
Buy 38%
Hold 19%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is a global leader in the household and personal care industry, with a strong focus on its namesake oral care line and international sales. The company has a solid portfolio of products, including pet food brand Hill's, and a well-established market presence in over 200 countries. Despite facing challenges in the form of increased costs and competitive activity, Colgate-Palmolive remains resilient and well-positioned for future growth. Its commitment to sustainability and social impact further strengthens its long-term outlook, making it a promising investment opportunity.

Bears say

Colgate-Palmolive is facing challenges in both its top line and gross margins, as macroeconomic pressures have resulted in slower growth and mixed performance across product categories. The company's exposure to resins and other oil derivatives, which account for 9% of its COGS, may continue to impact costs and margins. However, the company's organizational changes and international business strength could provide upside potential in the long term, and its hedging programs may help mitigate cost increases in the shorter term.

Colgate-Palmolive (CL) has been analyzed by 16 analysts, with a consensus rating of Buy. 44% of analysts recommend a Strong Buy, 38% recommend Buy, 19% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 16 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.